CONEXUS PHARMA
Last board
No change since 2014- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “De vennootschap wordt in en buiten rechte geldig vertegenwoordigd: - hetzij door één gedelegeerd bestuurder; - hetzij door twee bestuurders…”deed of 24-09-2013
Mandates through the years
5 namesDirector
Director
Managing director
Director
Managing director
Earlierend not dated
Mandates as a list
-
- Director, appointed by deed of 24-09-2013, last mentioned in 2014
-
- Director, appointed by deed of 24-09-2013, last mentioned in 2014
-
- Director, appointed by deed of 24-02-2014, last mentioned in 2014
- Managing director, appointed by deed of 24-02-2014, last mentioned in 2014
-
- Director, appointed by deed of 24-09-2013, last mentioned in 2014
-
- Director, appointed by deed of 24-09-2013, last mentioned in 2013
- Managing director, appointed by deed of 24-09-2013, last mentioned in 2013
Control
100%
This company
CONEXUS PHARMA
Equity €14,759
Loss €1,839 in 2016
Capital
- Capital
- €61,500
- Source
- 2016 annual accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 24-09-2013 (in Dutch)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Term of at most 6 yearsdeed of 24-09-2013 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Monday of May at 10:00deed of 24-02-2014 (in Dutch)
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 30-01-2018 ↗
- all shares
Stated in the deed
deed of 15-09-2017 ↗
- all shares